Cargando…
APOBEC3B up-regulation independently predicts ovarian cancer prognosis: a cohort study
BACKGROUND: Ovarian cancer is a heterogeneous disease with a high degree of genomic instability, pro-/antitumor immunity and inflammation, and remains the most lethal gynecologic cancer worldwide. APOBEC3B, a member of the AID/APOBEC family, is part of the innate immune system which plays a key role...
Autores principales: | Du, Yan, Tao, Xiang, Wu, Jing, Yu, Huandi, Yu, Yinhua, Zhao, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975489/ https://www.ncbi.nlm.nih.gov/pubmed/29853799 http://dx.doi.org/10.1186/s12935-018-0572-5 |
Ejemplares similares
-
Expression of PAWR predicts prognosis of ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2020) -
Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer
por: Liang, Leilei, et al.
Publicado: (2022) -
Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment
por: Vural, Suleyman, et al.
Publicado: (2018) -
Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer
por: Yu, Jing, et al.
Publicado: (2021) -
Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
por: Peng, Chen, et al.
Publicado: (2020)